Trail Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Trail Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TRAIL Protein | |
|---|---|
| Protein Name | TNF-Related Apoptosis-Inducing Ligand |
| Gene | TNFSF10 (TRAIL) |
| UniProt ID | P50591 |
| PDB Structures | 1D0G, 1D4V, 1DSG |
| Molecular Weight | 32.5 kDa (homotrimer) |
| Subcellular Localization | Cell surface, soluble |
| Protein Family | TNF Superfamily |
TRAIL is a type II transmembrane protein that forms homotrimers. The extracellular domain can be cleaved to generate a soluble form. TRAIL contains the characteristic TNF homology domain (THD) that mediates trimerization and receptor binding. The protein adopts a classic TNF-fold structure with a β-sandwich.
TRAIL induces apoptosis by binding to death receptors DR4 (TRAIL-R1) and DR5 (TRAIL-R2), which recruit FADD and caspase-8 to form the death-inducing signaling complex (DISC). Additionally, TRAIL can bind to decoy receptors DcR1 (TRAIL-R3) and DcR2 (TRAIL-R4) that cannot signal apoptosis and may act as scavengers.
In neurodegeneration, TRAIL:
Trail Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Trail Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.